RE:RE:RE:RE:RE:Marshall interview @Critical, I agree with your comment, however, given SCRN markets itself as a COVID screening business, it's somewhat hard to project beyond the next 6 months, at this time.
Granted, testing is likely to carry on for some time - especially given the impact of variants and unknown impacts on immunized populations - but it's difficult to define until when.
When investing, it's important to get a sense of timeline. So, until the CEO better defines the future of SCRN, <investors> will mostly project themselves in weeks and months, rather than years. Perhaps one of the reasons why the sp struggles to fly, as it should, given short term income expectations.
My two cents.
CriticalMind55 wrote: OHSTweeter, from what I am deciphering from your resent posts, you are short pretending to be long, but I do not expect you to admit it...